Plasma viral HIV-1 RNA level , CD4 + T-cell counts , and drug resistance were evaluated among seroconverting women in the FEM-PrEP trial ( clinicaltrials.gov NCT00625404 ) using standard clinical tests , allele-specific PCR ( ASPCR ) , and by deep sequencing .